[1]石 娴,傅曼妮,解翠林.原发性舍格伦综合征患者血清miR-193b 表达水平及其临床价值研究[J].现代检验医学杂志,2023,38(04):126-130.[doi:10.3969/j.issn.1671-7414.2023.04.023]
　SHI Xian,FU Manni,XIE Cuilin.Study on the Expression Level of miR-193b in Serum and Its Clinical Value in Patients with Primary Sjogren’s Syndrome[J].Journal of Modern Laboratory Medicine,2023,38(04):126-130.[doi:10.3969/j.issn.1671-7414.2023.04.023]
点击复制

原发性舍格伦综合征患者血清miR-193b 表达水平及其临床价值研究()
分享到：

《现代检验医学杂志》[ISSN:/CN:]

卷:
第38卷
期数:
2023年04期
页码:
126-130
栏目:
论著
出版日期:
2023-07-15

文章信息/Info

Title:
Study on the Expression Level of miR-193b in Serum and Its Clinical Value in Patients with Primary Sjogren’s Syndrome
文章编号:
1671-7414（2023）04-126-05
作者:
石 娴; 傅曼妮; 解翠林
（鄂东医疗集团黄石市中心医院/ 湖北理工学院附属医院皮肤科，湖北黄石 435000）
Author(s):
SHI Xian;  FU Manni;  XIE Cuilin
（Department of Dermatology, Huangshi Central Hospital of Eastern Hubei Medical Group /Affiliated Hospital of Hubei Institute of Technology, Hubei Huangshi 435000, China）
关键词:
原发性舍格伦综合征; 自身免疫病; miR-193b
分类号:
R593.2；R392.11
DOI:
10.3969/j.issn.1671-7414.2023.04.023
文献标志码:
A
摘要:
目的　探讨原发性舍格伦综合征（primary Sjogren’s syndrome，pSS）患者血清中miR-193b表达变化以及临床意义。方法　选取2015 年9 月～ 2020 年9 月在黄石市中心医院治疗的98 例pSS 患者作为病例组，45 例健康体检者作为对照组。根据患者病情严重程度分为轻度组（n=31）、中度组（n=43）和重度组（n=24）。收集临床资料，实时荧光定量PCR 法检测血清中miR-193b 表达量，采用Pearson 相关分析分析pSS 患者血清中miR-193b 表达量和临床指标间相关性，采用受试者工作特征（ROC）曲线分析血清中miR-193b 表达量对pSS 患者诊断价值。结果　pSS 患者血清中miR-193b表达量在对照组、pSS 轻度组、pSS 中度组和pSS 重度组依次升高（1.79±0.311，1.91±0.21，2.46±0.25，3.11±0.22），差异有统计学意义（F=165.948，P<0.001），且pSS 重度组>pSS 中度组>pSS 轻度组> 对照组（t=10.720, 9.924, 2.029,均P<0.05)；Pearson 相关分析结果显示，pSS 患者血清中miR-193b 表达量与B 细胞比例、ESR，IgG，ESSDAI 评分和ESSPRI 评分呈正相关（r=0.432，0.554，0.448，0.356 和0.361，均P<0.05），而与白细胞数、唾液流率和泪流率呈负相关（r=-0.215，-0.323，-0.369，均P<0.05）；ROC 曲线分析结果显示，血清中miR-193b 表达量在预测pSS 发生时曲线下面积为0.864（95%CI：0.805 ～ 0.923），当血清中miR-193b 表达量为2.06 时，灵敏度和特异度分别为78.57%，82.22%。结论　miR-193b 在pSS 患者血清中表达量升高，与pSS 病情轻重和患者腺体分泌有关，检测血清miR-193b有助于诊断pSS。
Abstract:
Objective　To investigate the change and significance of the expression of miR-193b in the serum of patients with primary Sjogren's syndrome (pSS). Methods　 A total of 98 cases of pSS patients treated in Huangshi Central Hospital were selected from September 2015 to September 2020, and 45 healthy subjects were served as the control group. According to the severity of the patient’s condition, patients were divided into mild group (n=31), moderate group (n=43) and severe group (n=24). The clinical data was collected. The expression of miR-193b in the serum was detected by using real-time fluorescent quantitative PCR. Pearson correlation analysis was used to analyze the correlation between the expression of miR-193b in serum of pSS patients and clinical indicators, and receiver operating characteristic curve (ROC) was used to analyze the diagnostic value of the expression of miR-193b in the serum for pSS patients. Results　The relative expression levels of miR-193b in the serum of pSS patients in the control group, mild group, moderate group and severe group were 1.79±0.31, 1.91±0.21, 2.46±0.25 and 3.11±0.22, repectively, and the difference was statistically significant(F=165.948, P<0.001), and the severe group>moderate group>mild group>control group (t=10.720, 9.924, 2.029, all P<0.05). Pearson correlation analysis results showed that the expression level of miR-193b in the serum of pSS patients was positively correlated with the proportion of B cells, ESR, IgG, ESSDAI score and ESSPRI score (r=0.432, 0.554, 0.448, 0.356 and 0.361, all P<0.05), while it was negative correlated with the number of white blood cells, saliva flow rateand tear flow rate(r=-0.215, -0.323, -0.369, all P<0.05). ROC curve analysis results showed that the area under the curve for the expression level of miR-193b in the serum when predicting the occurrence of pSS was 0.864 (95% CI: 0.805 ～ 0.923). When the expression level of miR-193b in the serum was 2.06, the sensitivity and the specificity were 78.57% ，82.22%，respectively. Conclusion　The expression level of miR-193b in the serum of pSS patients was elevated, which was related to disease activity and gland function. It is expected to be a serum marker for early diagnosis of pSS patients.

参考文献/References:

[1] 王静, 佘春晖, 刘斌. 原发性干燥综合征的研究进展[J]. 中国药物与临床, 2019, 19(16): 2762-2763. WANG Jing, SHE Chunhui, LIU Bin .Research progress of primary Sj?gren’s syndrome [J]. Chinese Remedies & Clinics, 2019, 19(16): 2762-2763.
[2] ODANI T, CHIORINI J A. Targeting primary Sj?gren’s syndrome[J]. Modern Rheumatology, 2019, 29(1): 70-86.
[3] 黄侠, 田瑞, 龚书识, 等. 原发性干燥综合征的研究进展[J]. 湖北民族学院学报( 医学版), 2019, 36(4):56-59. HUANG Xia, TIAN Rui, GONG Shushi, et al. Research progress of primary Sj?gren’s syndrome [J]. Journal of Hubei Minzu University(Medical Edition), 2019, 36(4): 56-59.
[4] CHEN Liang, HEIKKINEN L, WANG Changliang, et al. Trends in the development of miRNA bioinformatics tools[J]. Briefings in Bioinformatics, 2019, 20(5): 1836-1852.
[5] BOSISIO D, GIANELLO V, SALVI V, et al. Extracellular miRNAs as activators of innate immune receptors[J]. Cancer Letters, 2019, 452: 59-65.
[6] SHIRANI F, BAGHI M, ROSTAMIAN DELAVAR M, et al. Upregulation of miR-9 and miR-193b over human Th17 cell differentiation[J]. Molecular Genetics & Genomic Medicine, 2020, 8(12): e1538.
[7] HEUS A, ARENDS S, VAN NIMWEGEN J F, et al. Pulmonary involvement in primary Sj?gren’s syndrome, as measured by the ESSDAI[J]. Scandinavian Journal of Rheumatology, 2020, 49(1): 38-46.
[8] 岳晓琳, 米晓燕, 白圆圆, 等. 原发性舍格伦综合征患者血浆弗林蛋白酶和Th1 型细胞因子水平表达与唇腺损害及相关腺体功能的关系研究[J]. 现代检验医学杂志, 2021, 36(4): 10-14, 50. YUE Xiaolin, MI Xiaoyan, BAI Yuanyuan, et al. Relationship between plasma FURIN and Th1 type cytokines level, labial gland damage and related glandular function in patients with primary Sj?gren’s syndrome [J]. Journal of Modern Laboratory Medicine, 2021, 36(4): 10-14, 50.
[9] 魏超楠, 原艳妮, 张琳琳, 等. 唇腺病理活检在干燥综合征疾病中的应用及价值[J]. 河南大学学报(医学版), 2021, 40(6): 425-428. WEI Chaonan, YUAN Yanni, ZHANG Linlin, et al. The application and value of labial gland pathological biopsy in Sj?gren’s syndrome [J]. Journal of Henan University(Medical Science), 2021, 40(6): 425-428.
[10] YANG Xiaoyun, ZHAO Chunling, BAMUNUARACHCHI G, et al. MiR-193b represses influenza a virus infection by inhibiting Wnt/β-catenin signalling[J]. Cellular Microbiology, 2019, 21(5): e13001.
[11] SPECJALSKI K, JASSEM E. MicroRNAs: potential biomarkers and targets of therapy in allergic diseases[J]. Archivum Immunologiae Et Therapiae Experimentalis, 2019, 67(4): 213-223.
[12] 赵子艳, 孙健伟, 王丹丹, 等. miR-193b-3p 通过靶向RORα 抑制新生脓毒症大鼠的神经炎症反应[J].中华神经医学杂志, 2021, 20(11): 1092-1100. ZHAO Ziyan, SUN Jianwei, WANG Dandan, et al. Micro RNA-193b-3p inhibits neuro-inflammatory response in neonatal sepsis rats by targeting retinoic acid receptor-related orphan receptor α[J]. Chinese Journal of Neuromedicine, 2021, 20(11): 1092-1100.
[13] HUANG Cong, ZHONG Weilong, REN Xuanyao, et al. MiR-193b-3p-ERBB4 axis regulates psoriasis pathogenesis via modulating cellular proliferation and inflammatory-mediator production of keratinocytes[J]. Cell Death Dis, 2021, 12(11): 963.
[14] SEMBLER-M?LLER M L, BELSTR?M D, LOCHT H, et al. Distinct microRNA expression profiles in saliva and salivary gland tissue differentiate patients with primary Sj?gren’s syndrome from non-Sj?gren’s sicca patients[J]. Journal of Oral Pathology & Medicine, 2020, 49(10): 1044-1052.
[15] 吴志红, 杨硕. 益胃汤治疗阴虚津亏型原发性干燥综合征临床研究[J]. 河北中医, 2020, 42(5): 687-691. WU Zhihong, YANG Shuo. Clinical study of Yiwei decoction on primary Sj?gren’s syndrome of Yin-body fluid deficiency type [J]. Hebei Journal of Traditional Chinese Medicine, 2020, 42(5): 687-691.
[16] 李奔, 李丹, 薛鸾. 外周血CXC 型趋化因子配体13检测在原发性干燥综合征患者中的临床意义[J]. 中华风湿病学杂志, 2020, 24(2): 101-106. LI Ben, LI Dan, XUE Luan. The clinical significance of serum CXC-chemokine ligand 13 in primary Sj?gren’s syndrome[J]. Chinese Journal of Rheumatology, 2020, 24(2): 101-106.
[17] 苗宇桐, 周佳卉, 冯娟, 等. B 淋巴细胞在腹主动脉瘤发病中的作用[J]. 中国动脉硬化杂志, 2020,28(9): 737-743. MIAO Yutong, ZHOU Jiahui, FENG Juan, et al. Role of B lymphocyte in the development of abdominal aortic aneurysm[J]. Chinese Journal of Arteriosclerosis, 2020, 28(9): 737-743.
[18] PONTARINI E, SCIACCA E, GRIGORIADOU S, et al. NKp30 receptor upregulation in salivary glands of Sj?gren's syndrome characterizes ectopic lymphoid structures and is restricted by rituximab treatment[J]. Frontiers in Immunology, 2021, 12: 706737.

相似文献/References:

[1]俞 静,朱群英,陈 燕.原发性舍格伦综合征患者外周血Th22细胞水平的变化及其临床意义[J].现代检验医学杂志,2016,31(05):69.[doi:10.3969/j.issn.1671-7414.2016.05.018]
　YU Jing,ZHU Qun-ying,CHEN Yan.Change of Th22 Cells in Peripheral Blood of Patients with Primary Sjogren's Syndrome and Clinical Significance[J].Journal of Modern Laboratory Medicine,2016,31(04):69.[doi:10.3969/j.issn.1671-7414.2016.05.018]
[2]刘欢欢,潘发明,陈礼文.抗核小体抗体和抗 Sm 抗体鉴别诊断系统性红斑狼疮的 Meta 分析[J].现代检验医学杂志,2021,36(03):1.[doi:10.3969/j.issn.1671-7414.2021.03.001]
　LIU Huan-huan,PAN Fa-ming,CHEN Wen-li.Value of Antinucleosome Antibody and Anti-Sm Antibody in the DifferentialDiagnosis of Systemic Lupus Erythematosus：A Meta-Analysis[J].Journal of Modern Laboratory Medicine,2021,36(04):1.[doi:10.3969/j.issn.1671-7414.2021.03.001]
[3]岳晓琳,米晓燕,白圆圆,等.原发性舍格伦综合征患者血浆弗林蛋白酶和Th1型细胞因子水平表达与唇腺损害及相关腺体功能的关系研究[J].现代检验医学杂志,2021,36(04):10.[doi:10.3969/j.issn.1671-7414.2021.04.003]
　YUE Xiao-lin,MI Xiao-yan,Bai Yuan-yuan,et al.Relationship between Plasma FURIN and Th1 Type Cytokines Level, LabialGland Damage and Related Glandular Function in Patients with PrimarySjogren’s Syndrome[J].Journal of Modern Laboratory Medicine,2021,36(04):10.[doi:10.3969/j.issn.1671-7414.2021.04.003]
[4]杨彩红a,萧韵健a,袁 飞a,等.原发性舍格伦综合征患者血清ADAM17 表达水平及其与病情程度的相关性研究[J].现代检验医学杂志,2023,38(06):131.[doi:10.3969/j.issn.1671-7414.2023.06.024]
　YANG Caihonga,XIAO Yunjiana,YUAN Feia,et al.Study on the Expression Level of Serum ADAM17 in Patients with Primary Sjogren’s Syndrome and Its Correlation with the Severity of the Disease[J].Journal of Modern Laboratory Medicine,2023,38(04):131.[doi:10.3969/j.issn.1671-7414.2023.06.024]
[5]邓正鑫a,刘惠杰b,冯长州a,等.原发性舍格伦综合征患者血清MPO-DNA 水平与疾病活动度的相关性研究[J].现代检验医学杂志,2024,39(05):102.[doi:10.3969/j.issn.1671-7414.2024.05.019]
　DENG Zhengxina,LIU huijieb,FENG Changzhoua,et al.Study on the Correlation between Serum MPO-DNA Levels and Disease Activity in Patients with Primary Sj?gren’s Syndrome[J].Journal of Modern Laboratory Medicine,2024,39(04):102.[doi:10.3969/j.issn.1671-7414.2024.05.019]

备注/Memo

备注/Memo:
作者简介：石娴（1981-），女，医学硕士，副主任医师，研究方向：皮肤病和性病学，E-mail：3219475565@qq.com。
通讯作者：傅曼妮，E-mail：45995760@qq.com。
更新日期/Last Update: 2023-07-15